Table 1.
Demographic and baseline characteristics of the study participants (N = 30).
| Variable | Total participants | Group 1 A-B-D-C | Group 2 B-C-A-D | Group 3 C-D-B-A | Group 4 D-A-C-B | P value |
|---|---|---|---|---|---|---|
| Sex, No. (%) | ||||||
| Male | 14 (46.7%) | 3 (42.9%) | 5 (71.4%) | 4 (50.0%) | 2 (25.0%) | .35 |
| Female | 16 (53.3%) | 4 (57.1%) | 2 (28.6%) | 4 (50.0%) | 6 (75.0%) | |
| Total | 30 | 7 | 7 | 8 | 8 | |
| Age, y | .16 | |||||
| Mean ± SD | 63.2 ± 3.0 | 65.4 ± 2.4 | 62.6 ± 2.2 | 62.6 ± 2.8 | 62.3 ± 3.8 | |
| Min–max | 60–71 | 62–68 | 60–65 | 60–67 | 60–71 | |
| Baseline % bleeding on probing score, mean ± SD | 44.4 ± 18.2 | 51.3 ± 9.5 | 41.2 ± 17.4 | 43.4 ± 27.1 | 42.0 ± 15.1 | .73 |
| Baseline plaque index score, mean ± SD | 2.7 ± 0.7 | 2.9 ± 0.7 | 2.3 ± 0.6 | 2.9 ± 0.6 | 2.6 ± 0.7 | .22 |